Harold E. Windschitl

3.3k total citations
41 papers, 2.5k citations indexed

About

Harold E. Windschitl is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Harold E. Windschitl has authored 41 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Harold E. Windschitl's work include Colorectal Cancer Treatments and Studies (11 papers), Cancer Treatment and Pharmacology (10 papers) and Genetic factors in colorectal cancer (7 papers). Harold E. Windschitl is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Cancer Treatment and Pharmacology (10 papers) and Genetic factors in colorectal cancer (7 papers). Harold E. Windschitl collaborates with scholars based in United States, Canada and Germany. Harold E. Windschitl's co-authors include Charles L. Loprinzi, Jeff A. Sloan, Paul J. Novotny, Daniel J. Sargent, Debra L. Barton, Beth LaVasseur, Nathan R. Foster, James E. Krook, Richard M. Goldberg and Ralph Levitt and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Harold E. Windschitl

41 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harold E. Windschitl United States	25	1.4k	557	539	476	392	41	2.5k
Janet L. Stanford United States	26	1.1k 0.8×	379 0.7×	783 1.5×	817 1.7×	598 1.5×	45	3.4k
Jarley Koo Canada	19	1.2k 0.9×	289 0.5×	679 1.3×	249 0.5×	199 0.5×	29	2.1k
John C. Michalak United States	19	1.0k 0.8×	242 0.4×	278 0.5×	367 0.8×	299 0.8×	24	1.9k
Thomas A. Colacchio United States	27	1.1k 0.8×	399 0.7×	296 0.5×	561 1.2×	144 0.4×	65	2.6k
Helena Jernström Sweden	28	1.2k 0.9×	334 0.6×	822 1.5×	333 0.7×	498 1.3×	107	2.7k
Mark P. Ettinger United States	23	1.8k 1.3×	286 0.5×	966 1.8×	147 0.3×	327 0.8×	30	3.4k
Clara Chen United States	24	832 0.6×	206 0.4×	604 1.1×	401 0.8×	155 0.4×	101	2.6k
N. H. Bjarnason Denmark	18	1.2k 0.9×	384 0.7×	793 1.5×	113 0.2×	643 1.6×	31	3.1k
S. Friis Denmark	25	586 0.4×	157 0.3×	430 0.8×	439 0.9×	235 0.6×	52	2.4k
Srilatha Swami United States	28	779 0.6×	1.8k 3.3×	823 1.5×	601 1.3×	552 1.4×	38	3.4k

Countries citing papers authored by Harold E. Windschitl

Since Specialization

Citations

This map shows the geographic impact of Harold E. Windschitl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold E. Windschitl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold E. Windschitl more than expected).

Fields of papers citing papers by Harold E. Windschitl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold E. Windschitl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold E. Windschitl. The network helps show where Harold E. Windschitl may publish in the future.

Co-authorship network of co-authors of Harold E. Windschitl

This figure shows the co-authorship network connecting the top 25 collaborators of Harold E. Windschitl. A scholar is included among the top collaborators of Harold E. Windschitl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold E. Windschitl. Harold E. Windschitl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dy, Grace K., Timothy J. Hobday, Garth D. Nelson, et al.. (2009). Long-Term Survivors of Metastatic Colorectal Cancer Treated with Systemic Chemotherapy Alone: A North Central Cancer Treatment Group Review of 3811 Patients, N0144. Clinical Colorectal Cancer. 8(2). 88–93. 59 indexed citations

Rego, Rafaela L., Nathan R. Foster, Thomas C. Smyrk, et al.. (2009). Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status. British Journal of Cancer. 102(1). 165–172. 83 indexed citations

Johnson, Elizabeth A., Randolph S. Marks, Sumithra J. Mandrekar, et al.. (2007). Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Lung Cancer. 60(2). 200–207. 57 indexed citations

O’Connell, Michael J., Daniel J. Sargent, Harold E. Windschitl, et al.. (2006). Randomized Clinical Trial of High-Dose Levamisole Combined with 5-Fluorouracil and Leucovorin as Surgical Adjuvant Therapy for High-Risk Colon Cancer. Clinical Colorectal Cancer. 6(2). 133–139. 25 indexed citations

Jatoi, Aminah, et al.. (2002). Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Supportive Care in Cancer. 10(1). 71–75. 21 indexed citations

Gradishar, William J., Patricia Stephenson, Donna Glover, et al.. (2001). A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma. Cancer. 92(10). 2517–2522. 17 indexed citations

Jatoi, Aminah, Charles L. Loprinzi, Jeff A. Sloan, George G. Klee, & Harold E. Windschitl. (2001). Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia. Cancer. 92(3). 629–633. 24 indexed citations

Burch, Patrick A., Georgene Schroeder, Cristine Allmer, et al.. (2000). Phase II Evaluation of Continuous-Infusion 5-Fluorouracil, Leucovorin, Mitomycin-C, and Oral Dipyridamole in Advanced Measurable Pancreatic Cancer. American Journal of Clinical Oncology. 23(5). 534–537. 11 indexed citations

Loprinzi, Charles L., John W. Kugler, Jeff A. Sloan, et al.. (1999). Lack of Effect of Coumarin in Women with Lymphedema after Treatment for Breast Cancer. New England Journal of Medicine. 340(5). 346–350. 121 indexed citations

10.

Grill, Joseph P., Randolph S. Marks, John W. Kugler, et al.. (1999). Paclitaxel and G-CSF in Previously Untreated Patients With Extensive Stage Small-Cell Lung Cancer. American Journal of Clinical Oncology. 22(5). 517–517. 48 indexed citations

11.

Pitot, Henry C., Donald B. Wender, Matthew J. O’Connell, et al.. (1997). Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.. Journal of Clinical Oncology. 15(8). 2910–2919. 220 indexed citations

12.

Loprinzi, Charles L., Jeff A. Sloan, Alexandra Hammer, et al.. (1997). Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.. Journal of Clinical Oncology. 15(3). 969–973. 128 indexed citations

13.

Ingle, James N., Donald I. Twito, Vera J. Suman, et al.. (1997). Evaluation of Intravenous 6-Thioguanine as First-Line Chemotherapy in Women with Metastatic Breast Cancer. American Journal of Clinical Oncology. 20(1). 69–72. 3 indexed citations

14.

Donohue, J H, Shauna T. Williams, Stephen Cha, et al.. (1995). Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study.. Journal of Clinical Oncology. 13(7). 1671–1678. 60 indexed citations

15.

Witzig, Thomas E., Louis Letendre, James B. Gerstner, et al.. (1995). Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial.. Journal of Clinical Oncology. 13(8). 2012–2015. 33 indexed citations

16.

Patel, Shreyaskumar, Larry K. Kvols, R. G. Hahn, et al.. (1990). A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate. Cancer. 66(4). 655–658. 24 indexed citations

17.

Windschitl, Harold E., Harry S. Wieand, James E. Krook, et al.. (1990). A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer. Cancer. 66(5). 853–856. 7 indexed citations

18.

Ingle, James N., Donald I. Twito, Daniel J. Schaid, et al.. (1988). Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.. Journal of Clinical Oncology. 6(5). 825–831. 23 indexed citations

19.

Krook, James E., James R. Jett, Thomas R. Fleming, et al.. (1985). A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 3(6). 842–848. 13 indexed citations

20.

Swaim, William R., et al.. (1971). Chronic myelogenous leukemia in Hodgkin's disease: Immunofluorescence of cells. Cancer. 27(3). 569–573. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact